CS227048B2 - Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives - Google Patents

Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives Download PDF

Info

Publication number
CS227048B2
CS227048B2 CS826357A CS635782A CS227048B2 CS 227048 B2 CS227048 B2 CS 227048B2 CS 826357 A CS826357 A CS 826357A CS 635782 A CS635782 A CS 635782A CS 227048 B2 CS227048 B2 CS 227048B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
urea
halogenergolinyl
diethyl
salts
Prior art date
Application number
CS826357A
Other languages
Czech (cs)
English (en)
Inventor
Jean Claude Dr Hilscher
Wolfgang Dr Kehr
Gerhard Dr Sauer
Herbert Dr Schneider
Helmut Dr Wachtel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CS227048B2 publication Critical patent/CS227048B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CS826357A 1981-01-14 1982-01-14 Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives CS227048B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813101535 DE3101535A1 (de) 1981-01-14 1981-01-14 Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
CS227048B2 true CS227048B2 (en) 1984-04-16

Family

ID=6122898

Family Applications (2)

Application Number Title Priority Date Filing Date
CS82303A CS227030B2 (en) 1981-01-14 1982-01-14 Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives
CS826357A CS227048B2 (en) 1981-01-14 1982-01-14 Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS82303A CS227030B2 (en) 1981-01-14 1982-01-14 Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives

Country Status (17)

Country Link
US (1) US4853390A (xx)
EP (1) EP0056358B1 (xx)
JP (1) JPS57145875A (xx)
AT (1) ATE26716T1 (xx)
AU (1) AU547987B2 (xx)
CA (1) CA1175043A (xx)
CS (2) CS227030B2 (xx)
DD (1) DD202027A5 (xx)
DE (2) DE3101535A1 (xx)
DK (1) DK161146C (xx)
ES (2) ES8304127A1 (xx)
GR (1) GR75159B (xx)
HU (1) HU186898B (xx)
IE (1) IE52849B1 (xx)
IL (1) IL64745A0 (xx)
SU (1) SU1097199A3 (xx)
YU (1) YU307181A (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3216870A1 (de) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen Pharmazeutische zubereitungen mit zytostatischer wirkung
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
PH21123A (en) * 1983-04-28 1987-07-27 Erba Farmitalia Ergoline derivatives
DE3410218A1 (de) * 1984-03-16 1985-09-19 Schering AG, Berlin und Bergkamen, 1000 Berlin Tergurid als antihypertensivum
DE3413657A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergoline
DE3413659A1 (de) * 1984-04-09 1985-10-17 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 2-substituierte ergolin-derivate
NL8503426A (nl) * 1984-12-24 1986-07-16 Sandoz Ag 8alfa-acylamino-ergolinen, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
DE3522894A1 (de) * 1985-06-24 1987-01-02 Schering Ag Verwendung von tergurid als geriatrikum
DE3533675A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-brom-ergolinderivate
DE3533672A1 (de) * 1985-09-19 1987-03-26 Schering Ag Neue 12- und 13-substituierte ergolinderivate
DE3535929A1 (de) * 1985-10-04 1987-04-09 Schering Ag 1,2-disubstituierte ergolinderivate
DE3535930A1 (de) * 1985-10-04 1987-04-09 Schering Ag Neue 2-substituierte ergolinderivate
US5242678A (en) * 1986-07-10 1993-09-07 Schering Aktiengesellschaft BR*-diagnostics for monoamine receptors
DE3623438C2 (de) * 1986-07-10 1998-04-09 Schering Ag In 2-Stellung mit radioaktivem Iod markierte Ergolinylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Diagnostika
GB8824744D0 (en) * 1988-10-21 1988-11-30 Erba Carlo Spa Antiemesis ergoline derivatives
DE10066158B4 (de) 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
GB0307377D0 (en) * 2003-03-31 2003-05-07 Merad Pharmaceuticals Ltd Ergoline derivatives
EP2083008A1 (en) * 2007-12-07 2009-07-29 Axxonis Pharma AG Ergoline derivatives as selective radical scavengers for neurons

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH573936A5 (xx) * 1971-08-05 1976-03-31 Spofa Vereinigte Pharma Werke
US4348392A (en) * 1974-07-19 1982-09-07 Sandoz Ltd. 8α-Substituted ergoline-I derivatives
GB1517972A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-cyanomethylergoline i
CH615929A5 (en) * 1975-06-02 1980-02-29 Sandoz Ag Process for the preparation of novel ergoline compounds
DE2656344A1 (de) * 1975-12-23 1977-07-07 Sandoz Ag Ergolinderivate, ihre verwendung und herstellung
DE2924102A1 (de) * 1979-06-13 1980-12-18 Schering Ag Neue (ergolin-yl)-n'.n'-diaethylharnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3063869D1 (en) * 1979-06-13 1983-07-28 Schering Ag (ergolin-yl)-n', n'-diethyl urea derivatives, their preparation and pharmaceutical compositions containing them
DE3001752A1 (de) * 1980-01-16 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin Verfahren zur herstellung von 8(alpha)-substituierten 6-methylergolinen
DE3101535A1 (de) * 1981-01-14 1982-08-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
DE3309493A1 (de) * 1983-03-14 1984-09-20 Schering AG, 1000 Berlin und 4709 Bergkamen Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel
DE3340025C2 (de) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 2-Brom-8-ergolinyl-Verbindungen

Also Published As

Publication number Publication date
ES8307802A1 (es) 1983-08-16
DE3101535A1 (de) 1982-08-12
EP0056358A1 (en) 1982-07-21
AU7929882A (en) 1982-07-22
SU1097199A3 (ru) 1984-06-07
IE52849B1 (en) 1988-03-30
DK161146C (da) 1991-11-11
JPS57145875A (en) 1982-09-09
YU307181A (en) 1983-12-31
DE3276114D1 (en) 1987-05-27
DK13382A (da) 1982-07-15
EP0056358B1 (en) 1987-04-22
DD202027A5 (de) 1983-08-24
ES508735A0 (es) 1983-03-01
IL64745A0 (en) 1982-03-31
AU547987B2 (en) 1985-11-14
ES8304127A1 (es) 1983-03-01
HU186898B (en) 1985-10-28
DK161146B (da) 1991-06-03
US4853390A (en) 1989-08-01
IE820066L (en) 1982-07-14
GR75159B (xx) 1984-07-13
JPH0437079B2 (xx) 1992-06-18
ATE26716T1 (de) 1987-05-15
ES517919A0 (es) 1983-08-16
CS227030B2 (en) 1984-04-16
CA1175043A (en) 1984-09-25

Similar Documents

Publication Publication Date Title
CS227048B2 (en) Method of preparing (2-halogenergolinyl)-n,n-diethylurea derivatives
US4379790A (en) (Erolinyl)-N,N-diethylurea derivatives, and their preparation and use
JPS6363544B2 (xx)
US4766128A (en) Optionally 11- to 13-substituted ergoline compounds useful as medicinal agents
EP0074921B1 (en) Process for the preparation of ergoline derivatives
DE3413657A1 (de) Neue ergoline
CS247089B2 (en) Production method of the 2-bromine-8-ergolinyl compounds
CS259893B2 (en) Method of ergoline's 1,2-disubstituted derivatives production
CS256364B2 (en) Method of 12 and 13 bromergoline's new derivatives production
CA2091455A1 (en) 2,14-disubstituted ergolines, their production and use in medicaments
CH641803A5 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes, et composition pharmaceutique les contenant.
AU652877B2 (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
US4859682A (en) 2-Halogenated-8- and 1,8-substituted ergolenes
HU193780B (en) Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof
FI66185B (fi) Nytt foerfarande foer bromering av foereningar
CS262450B2 (en) Process for preparing new derivatives of 1-aryl-ergolinurea
JPH0240647B2 (ja) Purorakuchinbunpyokuseizai
KR810002024B1 (ko) 6-n-프로필-8-메톡시메틸 또는 메틸 메르캅토 메틸 에르골린의 제조방법
HUT58093A (en) Process for producing 2,13-disubstituted ergolines and pharmaceutical compositions comprising same
CS259899B2 (cs) Způsob výroby nových 1,2-disubstituovaných derivátů ergolinu
JPH0240044B2 (ja) Paakinsonshokogunchiryozai
CS219363B1 (cs) Estery kyseliny N-[(5R,8S,10R)-6-propyl-8-ergolinyllkarbamové a způsoby jejich výroby
CS231229B1 (en) Processing method of 3-r-y-r1-substituted benzothiazel salts